ResMed (RMD) Tops Q1 EPS by 24c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
BofA Securities Upgrades ResMed (RMD:AU) (RMD) to Neutral
October 27, 2020 5:54 AM EDTBofA Securities analyst Lyanne Harrison upgraded ResMed (RMD:AU) (NYSE: RMD) from Underperform to Neutral with a price target of AUD0.00.
... More
